IL33 and neoplasm: Furthermore, the absence of mast cells inhibits intestinal-type gastric tumor growth, possibly due to IL-33’s influence on mast cells, hence promoting factors associated with macrophage growth, recruitment, and angiogenesis and supporting tumor growth [132].